Podcast appearances and mentions of Barry Kramer

In this episode we welcome not one but two guests and ask them to talk about their long-time friend and mentor Dave Marsh. Daniel Wolff and Danny Alexander co-edited 2023's Marsh anthology Kick Out the Jams: on the eve of his 75th birthday they reflect on his powerful writing, his impassioned politics and his career from Creem and Rolling Stone to the Rock & Roll (subsequently Rock & Rap) Confidential newsletter he launched in 1983. An audio clip of Dave being interviewed by Daniel for the Rock & Roll Hall of Fame takes us back to the former's championing of his Detroit contemporaries the MC5 and the Stooges. Meanwhile pieces about Creem itself and about his friend and frequent biographical subject Bruce Springsteen prompt our guests' amused thoughts on Dave's trenchant opinions and general combativeness.  A 1990 Vox piece about 'The Star-Spangled Banner' leads us to clips from a 1996 audio interview with one of Marsh's many Black music heroes: the sainted Curtis Mayfield. On the 60th anniversary of the Impressions' 'People Get Ready', we talk about the Chicago soul star's songs, politics, guitar-playing — and the sheer wisdom and serenity of the man. (News of the death of Mayfield's old friend and fellow Impression Jerry Butler only reached us the day after this episode was recorded.) After we've paid our respects to Jam drummer Rick Buckler, Jasper quotes from recently-added library interviews with Lil' Kim (1997) and Hipgnosis boss Merck Mercuriadis (2021). Many thanks to special guests Daniel Wolff and Danny Alexander. Kick Out the Jams: Jibes, Barbs, Tributes and Rallying Cries from 35 years of Music Writing by Dave Marsh is published by Simon & Schuster and available now from all good bookshops. Pieces discussed: Creem Reflects Detroit Rock 'n' Roll, Barry Kramer 1943–1981, Sour Creem, Bruce Springsteen: Shouldn't He Be Famous?, The Incredible Story of Iggy & the Stooges, 'The Star Spangled Banner', Curtis Mayfield audio, Rick Buckler, Lil' Kim and Merck Mercuriadis.

THE HEART OF ROCK ‘N' ROLL—There's a saying about the Velvet Underground's first album: it didn't sell a lot of copies but everyone who bought it went on to form a band. Not everyone who read Creem went on to form a band, but almost everyone who ever wrote about rock music in a significant way has a connection to Creem. Founded in Detroit in 1969 by Barry Kramer, Creem was a finger in the eye to the more established Rolling Stone. Creem called itself “America's Only Rock ‘n' Roll Magazine” and its cheeky irreverence matched its devotion to its infamous street cred. Punk, new wave, heavy metal, alternative, indie were all championed at Creem.Writers and editors who worked for Creem read like a who's who of industry legends: Lester Bangs. Dave Marsh. Robert Christgau. Greil Marcus. Patti Smith. Cameron Crowe. Jann Uhelszki. Penny Valentine. And on and on and on.The magazine stopped publishing in 1989 a few years after Barry's death. A documentary about Creem's heyday in 2020 helped lead to a resurrected media brand, founded by JJ Kramer, Barry's son, and launched in 2022. The copy on the first issue's cover: “Rock is Dead. So is Print.”Totally typical Creem-assed fuckery. And still totally rock n roll, man. Print Is Dead (Long Live Print!) is a production of Magazeum LLC ©2021–2025

NBA News, NFL News, MLB News, MLB Hotstove, WNBA News, NHL News, A Farewell to Brian Matusz, Peter Yarrow, Bob Veale, George Folsey Jr, John Capodice, Steve DiMeglio, Josh Welsh, Wayne Osmond, Jeff Baena, The Vivienne, Mike Rinder, Gwen Van Dam, Keller Fornes, Al MacNeil, Dwight Foster, Barry Kramer & Jonathan Stanko!

THE HEART OF ROCK 'N' ROLL IS STILL BEATING—There's a saying about the Velvet Underground's first album: it didn't sell a lot of copies but everyone who bought it went on to form a band. Not everyone who read Creem went on to form a band, but almost everyone who ever wrote about rock music in a significant way has a connection to Creem. Founded in Detroit in 1969 by Barry Kramer, Creem was a finger in the eye to the more established Rolling Stone. Creem called itself “America's Only Rock ‘n' Roll Magazine” and its cheeky irreverence matched its devotion to its infamous street cred. Punk, new wave, heavy metal, alternative, indie were all championed at Creem.Writers and editors who worked for Creem read like a who's who of industry legends: Lester Bangs. Dave Marsh. Robert Christgau. Greil Marcus. Patti Smith. Cameron Crowe. Jann Uhelszki. Penny Valentine. And on and on and on.The magazine stopped publishing in 1989 a few years after Barry's death. A documentary about Creem's heyday in 2020 helped lead to a resurrected media brand, founded by JJ Kramer, Barry's son, and launched in 2022. The copy on the first issue's cover: “Rock is Dead. So is Print.”Totally typical Creem-assed fuckery. And still totally rock n roll, man. ©2024 The Full-Bleed Podcast is a production of Magazeum LLC. Visit magazeum.co for more information.

Even tho they aren't absolutely crucial to the lore, the Disney worlds still exist

Each episode of Talk Evidence we take a dive into an issue or paper which is in the news, with a little help from some knowledgeable guests to help us to understand what it all means for clinical care, policy, or research.    In this episode: Helen Macdonald take a deep dive into cancer screening tests, prompted by a paper in JAMA which showed most have no effect on all cause mortality, and news that the NHS is evaluating a single test which screens for 50 common cancers - we ask Barry Kramer, former director of the Division of Cancer Prevention, at the U.S. National Cancer Institute to help explain how to hold those two pieces of knowledge. Juan Franco has been looking into diet and obesity, prompted by new research in The BMJ and a new Cochrane review, looking at the role of low glycemic index foods in weightloss - we ask Khadidja Chekima, nutritional researcher at Taylor's University in Malaysia, to define low GI foods, and why it's so hard to research their role in diet and weightloss    Reading list; JAMA research - Estimated Lifetime Gained With Cancer Screening Tests; A Meta-Analysis of Randomized Clinical Trials The BMJ news - Clinicians raise concerns over pilot of blood test for multiple cancers The BMJ research - Association between changes in carbohydrate intake and long term weight changes: prospective cohort study Cochrane review - Low glycaemic index or low glycaemic load diets for people with overweight or obesity

Each episode of Talk Evidence we take a dive into an issue or paper which is in the news, with a little help from some knowledgeable guests to help us to understand what it all means for clinical care, policy, or research.    In this episode: Helen Macdonald take a deep dive into cancer screening tests, prompted by a paper in JAMA which showed most have no effect on all cause mortality, and news that the NHS is evaluating a single test which screens for 50 common cancers - we ask Barry Kramer, former director of the Division of Cancer Prevention, at the U.S. National Cancer Institute to help explain how to hold those two pieces of knowledge. Juan Franco has been looking into diet and obesity, prompted by new research in The BMJ and a new Cochrane review, looking at the role of low glycemic index foods in weightloss - we ask Khadidja Chekima, nutritional researcher at Taylor's University in Malaysia, to define low GI foods, and why it's so hard to research their role in diet and weightloss    Reading list; JAMA research - Estimated Lifetime Gained With Cancer Screening Tests; A Meta-Analysis of Randomized Clinical Trials The BMJ news - Clinicians raise concerns over pilot of blood test for multiple cancers The BMJ research - Association between changes in carbohydrate intake and long term weight changes: prospective cohort study Cochrane review - Low glycaemic index or low glycaemic load diets for people with overweight or obesity

Today I review the Amazon/Coda Collection documentary on the pioneering and irreverent rock and roll magazine CREEM. I share what I thought were the strongest points in the film, as well as the parts where I felt there was room for improvement. I also go in-depth into the origins, rise, collapse, and eventual return of CREEM magazine, and the tragic life of its late founder and head publisher Barry Kramer. ✨ MORE ABOUT THE CODA COLLECTION ✨ The Coda Collection is an Amazon Prime Video channel that lets you stream iconic music documentaries, concert films, and rare footage that provide an intimate and in-depth look into the world's greatest artists. Experience the stories between the songs of legendary artists including Jimi Hendrix, John Lennon, Foo Fighters, Aretha Franklin, Pearl Jam, Evanescence, Rolling Stones and more. ✨ CONNECT WITH IZZY ✨ YouTube: youtube.com/channel/UCv6SBgiYCpYbx9BOYNefkIg Website: agrrrlstwosoundcents.com Instagram: instagram.com/agrrrlstwosoundcents/ Twitter: twitter.com/grrrlsoundcents

Mitch Ryder, one of the most distinctive and soulful voices to come out of Detroit's 1960s rock music scene, will be inducted into the Rhythm and Blues Hall of Fame June 11, at the Music Hall in Detroit.This year's crop of inductees also includes Patti LaBelle, Gladys Knight & the Pips, the Impressions, Larry Williams, and posthumous inductees James Brown, Isaac Hayes and Mary Wells.Ryder may have fronted a rock band, but make no mistake, his soul props are solid. As a suburban teenager, he made the trek from Warren to hang out at the Village club just off Woodward, to catch sets by the likes of Nathaniel Mayer. By the time he was 17, Ryder sang (and recorded) with a soul group, the Peps.Later he fronted his own rock band, Billy Lee and the Rivieras, which was renamed Mitch Ryder and the Detroit Wheels. The group had an explosive sound that combined the drive of garage rock with Ryder's raw, emotional vocals. That sound drove Bob Crewe-produced hits that included “Devil with a Blue Dress,” “Jenny Take A Ride,” “Sock it to Me, Baby” and “Little Latin Lupe Lu.”Ryder was pleased to hear of his induction alongside some of his soul idols. “I looked at the names of some of those who came before me and it became a celebration of joy for me,” Ryder said in a statement released by his publicist, Cary Baker. “I mean, Aretha Franklin, David Ruffin, Marvin Gaye, Otis Redding, Jackie Wilson, Sam Cooke and so many other voices that brought me great pleasure throughout my life and career. It is still thrilling me, and I'm afraid to wake up from the dream!”After the Wheels split up, Ryder teamed up with Booker T. and the MGs for the acclaimed album “The Detroit-Memphis Experiment.” Later, he joined back up with Wheels drummer Johnny Badanjek in a group they dubbed Detroit, which was managed by Creem magazine publisher Barry Kramer. Detroit recorded a memorable cover of Lou Reed's “Rock and Roll,” which many felt surpassed the original. Later, John Mellencamp produced Ryder's solo album “Never Kick a Sleeping Dog,” which featured his superb rendition of Prince's “When You Were Mine.”Ryder is on the short list of artists who have been unjustly overlooked by the Rock and Roll Hall of Fame, but in a sense, the Rhythm and Blues Hall of Fame is the more fitting place for him.For his part, Ryder says his induction is “an honor which will stay cherished by me for the rest of my life.”The 5th annual Black Tie Rhythm and Blues Hall of Fame Induction Ceremony and Concert will take place at 6 p.m. Sunday June 11 at the Music Hall, 350 Madison, in Detroit. The event will serve as a fundraiser to secure a permanent building for the Rhythm and Blues Hall of Fame. 

JJ Kramer, who is rebooting Creem Magazine, joins LaunchLeft today. JJ shares about the  impact of Creem Magazine and what it means to bring back the iconic magazine his father started in the 70s. He launches Zachary Lipez, the Editor at Large, who discusses his love for writing, music and even going into the office. Listen in on this enthusiastic conversation between music lovers about the history and future of Creem Magazine.  -----------------  LAUNCHLEFT OFFICIAL WEBSITEhttps://www.launchleft.com  LAUNCHLEFT PATREON https://www.patreon.com/LaunchLeft  TWITTER https://twitter.com/LaunchLeft  INSTAGRAM https://www.instagram.com/launchleft/  FACEBOOK https://www.facebook.com/LaunchLeft  --------------------- LaunchLeft Podcast hosted by Rain Phoenix is an intentional space for Art and Activism where famed creatives launch new artists. LaunchLeft is an alliance of left-of-center artists, a curated ecosystem that includes a podcast, label and NFT gallery. --------------------- IN THIS EPISODE: [02:43] JJ Kramer discusses the void created when Creem 1.0 had its last print run in 1989.  [09:44] How the magazine and the creator, JJ's father, Barry, are inextricably intertwined, and the desire to preserve the legacy.  [14:51] Bringing Zachary Lipez on as Editor at Large.  [17:10] Zachary tells how he began his writing career.  [29:53] The goal of Creem Magazine is to be true to itself and its readers.  KEY TAKEAWAYS:  Creem Magazine is based in Detroit and focuses on all genres of music, making it a magazine for everyone. Creem Magazine tells it like it is. It embraces humor, clarity, opinions, the music culture, criticism, and praise of the musician or band. Detroit was and still is the home of Creem Magazine. It pays homage to its Detroit roots but is a magazine for anyone and everyone who loves music. RESOURCE LINKS Website - Creem Magazine Facebook - Creem Magazine Twitter - Creem Magazine Instagram - Creem Magazine Facebook - JJ Kramer Facebook - Zachary Lipez Linkedin - JJ Kramer Linkedin - Zachary Lipez BIO:  JJ Kramer, Chairman, CREEM Magazine JJ Kramer is the only child of CREEM's late founder, Barry Kramer.  After his father's death in 1981, CREEM was bequeathed to JJ who, at four years old, was named the magazine Chairman. For the better part of his adult life, JJ has been fighting to preserve CREEM's storied legacy (including an actual fist fight). In 2022, JJ comes full circle and resumes his role as Chairman of CREEM Entertainment. In addition, as a practicing intellectual property and entertainment attorney with 20 years of experience, JJ has worked with some of the world's biggest brands, influencers, and recording artists.    Zachary Lipez, Editor at Large, CREEM Magazine Zachary Lipez is a writer and bartender based in NYC. His byline has appeared in The Washington Post, Talkhouse, VICE/Noisey, Bandcamp Daily, Pitchfork, The Fader, and Penthouse. He is the co-author (with Stacy Wakefield and Nick Zinner) of 131 Different Things, Please Take Me Off The Guestlist, Slept In Beds, and No Seats On The Party Car. He sang in the post-punk band Freshkills (about which he wrote the Talkhouse essay, “Playing in a Band No One Likes”). He is currently the singer in two bands, Publicist UK and Telematics, both goth-adjacent.See omnystudio.com/listener for privacy information.

JJ Kramer, the only child of CREEM Magazine's late founder, Barry Kramer, inherited CREEM at age four when his father died.  CREEM, published from 1969 through 1989  in Detroit, was an early champion of various heavy metal, punk rock, new wave, and alternative bands, and left an indelible mark on the music industry. JJ has made it his life's mission to revive CREEM and successfully did so in 2022. We talk to him about legacy, and what he's teaching his own kids about rock and roll!The winter issue of CREEM will be released December 15. Get 25% off your subscription today and up to 50% off apparel for a special Black Friday sale. https://www.creem.com/Also, check out the CREEM documentary on Amazon Prime:https://www.creem.com/documentarySupport the show

Hi everyone! Welcome back to “Billy's Bubble” here on Drum Channel. My bubble show is a bit different from my regular weekly podcasts, but the lesson and message is always the same; learning words of wisdom with knowledgeable, successful guests. This episode is a business theme with my guests Chairman (and son of Creem magazine's co-founder Barry Kramer), JJ Kramer along with CEO/Publisher John Martin. Anyone from my generation may recognize the magazine or be reminded; I grew up reading it as a young teenager. It was around for twenty years and then disappeared for over twenty more. Now, it's back in both monthly digital and four issues a year of print.  Creem magazine was a ground-breaking music magazine back in the day and I'm happy to say, they're picking up right where they left off. Let's listen. Enjoy!

Afternoons 3-6 on 105.9 The X THE LIST. Mark is joined by JJ Kramer, the son of Barry Kramer who founded Creem Magazine. JJ talks with MArk about his venture to relaunch the iconic magazine after a 30 year hiatus. ASK MARK ANYTHING!!!

JJ Kramer serves as Vice President, Associate General Counsel & Global Head of Intellectual Property at Abercrombie & Fitch where he manages the company's robust global IP portfolio and provides strategic counsel on trademark, copyright, patent, trade secret, right of publicity, domain name, licensing entertainment, and social media matters. JJ is also Chairman & CEO of CREEM Magazine, the legendary rock ‘n' roll publication founded in Detroit in 1969 by JJ's late father, Barry Kramer. After his father's death in 1981, CREEM was bequeathed to JJ who, for the better part of his adult life, has been on a mission to preserve CREEM's storied legacy.   Connect with Jon Dwoskin: Twitter: @jdwoskin Facebook: https://www.facebook.com/jonathan.dwoskin Instagram: https://www.instagram.com/thejondwoskinexperience/ Website: https://jondwoskin.com/LinkedIn: https://www.linkedin.com/in/jondwoskin/ Email: jon@jondwoskin.com Get Jon's Book: The Think Big Movement: Grow your business big. Very Big! Connect with Jamie Garavaglia: Website: www.jamiegconsulting.com Instagram: https://www.instagram.com/jamieg_virtualadminconsultant/ Facebook: https://www.facebook.com/Jamie-Gavaglia-Virtual-Administrative-Consultant-102494711546751 LinkedIn: https://www.linkedin.com/company/jamie-garavaglia-virtual-administrative-consultant

In this two-part episode of Oncology, Etc., hosts Dr. Patrick Loehrer (Indiana University) and Dr. David Johnson (University of Texas) speak with Dr. Otis Brawley, a Bloomberg Distinguished Professor of Oncology at Johns Hopkins and former Executive Vice President of the American Cancer Society, about his incredible life and career. Subscribe: Apple Podcasts, Google Podcasts | Additional resources: education.asco.org | Contact Us Air Date: 9/7/2021   TRANSCRIPT SPEAKER: The purpose of this podcast is to educate and inform. This is not a substitute for medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. No mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. PAT LOEHER: Hi. I'm Pat Loeher. I'm director of the Centers of Global Oncology and Health Equity at Indiana University Melbourne and Bren Simon Cancer Center. DAVID JOHNSON: And good morning. I'm Dave Johnson. I'm professor of Internal Medicine Oncology at the University of Texas Southwestern in Dallas. We're really excited to be back with the second episode of our ASCO Educational Podcast Oncology, et cetera. And I don't know about you, but my arm's really sore from entering all the fan mail we got from the first episode. Either that or maybe it was that shingles shot I got last week I don't know. PAT LOEHER: No, I agree. I really appreciate Bev. Your wife just kept texting me how wonderful I was, and it was-- I enjoyed it. DAVID JOHNSON: Well, I'm glad you mentioned that, because I wanted to read this one fan mail. It says, dear, Dave. Thanks for carrying Pat [INAUDIBLE]. I don't know who that is, but I appreciate it. PAT LOEHER: Yeah, it works both ways. Works both ways. So what have you been reading lately, Dave? DAVID JOHNSON: Well, as you know, I love to read. And actually what I'm reading right now is The Howe dynasty by Julie Flavell. It's about the brothers Howe that were involved in the Revolutionary War. But the book I finished just prior to the one I'm reading now is Adam Grant's Think Again, which I really enjoyed. It made me think again. What about you? PAT LOEHER: How many times have you read the book by the way? DAVID JOHNSON: Again. Twice. PAT LOEHER: Think again. Yeah. There was the book that's called The One Thing. I know if you saw that book which I read a while back. It took me, like, a year to do it, because I just kept doing other things while I was reading it. I felt so guilty about it. I did read the book Caste recently, and it was on Oprah Winfrey's list. Barack Obama picked it. And actually read that on my way to Kenya a couple of months ago and found it very fascinating actually. You know, the notion of the juxtaposing of Nazi Germany, of the caste system in India, and the racial struggles that was going on here in this country. And I thought it was a very well written book. DAVID JOHNSON: Yeah. You mentioned that book to me, and I finished reading it a couple of weeks ago. I agree with you. I enjoy it very much. I learned a lot. We want to introduce today's guest. We're really, really fortunate to have with us today Dr. Otis Brawley. Dr. Brawley Is the Bloomberg Distinguished Professor of Oncology and Epidemiology at Johns Hopkins University. He's a graduate of the University of Chicago School of Medicine. He completed a residency in Internal Medicine at the University Hospitals in Cleveland Case Western Reserve and did a Fellowship in Medical Oncology at the National Cancer Institute, where he spent a good portion of his early career. In the 2000s, he relocated to Atlanta, where he became medical director of the Georgia Cancer Center for Excellence at Grady Memorial Hospital. One of the really most famous safety net hospitals in America. He was deputy director of Cancer Control at the Winship Cancer Institute of Emory University. And then he moved on to really a significant role. He became the chief medical and scientific officer and executive vise president of the American Cancer Society from 2007 to 2018, and we'll have a chance to perhaps query him about that. Currently, he leads a broad interdisciplinary research program on cancer health disparities at the Bloomberg School of Public Health and the Johns Hopkins Kimmel Cancer Center. Dr. Brawley has received innumerable awards. It would take the whole podcast to list them all. But among them are the American Medical Association Distinguished Service Award, University of Chicago Alumni of Professional Achievement Award, and-- one that I think is particularly poignant for ASCO members-- the Martin D. Abeloff Award for Excellence in Public Health and Cancer Control. In 2015, Dr. Brawley was elected to the National Academy of Medicine and well deserved. So just welcome to oncology, et cetera. Thank you so much for taking the time to be with us today. OTIS BRAWLEY: Thank you for having me. It's a pleasure to be with you and Pat. DAVID JOHNSON: Well, it's great to have you. I can tell you that. So let's just start with just a little background. Why don't you tell us about yourself? Where are you from? Where did you grow up? OTIS BRAWLEY: I grew up in Detroit. I grew up in one of the automobile worker neighborhoods, a blue collar neighborhood, and went to the Catholic schools there. The nuns in grade school pushed me toward the Jesuit school for high school, and the Jesuits in high school taught me how to think and really propelled me. And indeed much of my career, much of my writings, my philosophy toward medicine was really influenced by early education with the Jesuits. DAVID JOHNSON: Wow. PAT LOEHER: Hey, Otis. I just want to throw in-- in terms of books that we've read, one of the other books that I want to give a shout out is the book you wrote called How We Do Harm, which was really a wonderful book. I think it was several years in the making. Would love to hear how you made that. But I do-- while you're talking about your background, speak a little bit about Edward McKnight Brawley and Benjamin. OTIS BRAWLEY: Oh, OK. Benjamin Brawley was my grandfather's brother, and Edward McKnight Brawley was my grandfather's father. They're both ministers in the Methodist Church, the AME Church. Benjamin Brawley was dean of Morehouse College back in the 1920s, and he was the first Brawley to graduate from the University of Chicago. He got a PhD from the University of Chicago back during the 19-teens. And those are just a couple of my relatives. If you go to Morehouse, you'll find that the English building is Benjamin Brawley Hall, and Edward McKnight Brawley was his father and was a free Black back before the Civil War, and a minister before, during, and after. PAT LOEHER: Incredible legacy. Incredible legacy. DAVID JOHNSON: Those were your relatives from the South from the Georgia area? OTIS BRAWLEY: Well, my father grew up in Northwestern Alabama. An area called Leighton, Alabama. It's near Muscle Shoals. So those of us who remember the Beverly Hillbillies. My mother is from the middle of Arkansas. She's from Pine Bluff, Arkansas. And they met in Detroit. They were part of that northern migration in the early 20th century, where a large number of Blacks left the rural South and went up North to get jobs primarily in the industrial North. My father arrived there right after World War II. He served in World War II, got discharged, and went to Detroit. My mother actually went to Detroit really early on during World War II and worked in an airplane factory during the war. Then the two of them met. My father was a janitor at the Veterans Hospital in Detroit, and my mother worked in the cafeteria there. And that's how they met. They had my older sister, who was 8 years older than me, who became an attorney. And my younger sister was a certified public accountant. PAT LOEHER: What a remarkable story for your parents. And tell us a little bit about your journey to become a physician. How did that happen? OTIS BRAWLEY: It was very interesting. In high school, I was very talkative. I was very interested in policy. I did debate. It was very not a sciencey kind of person. In college, I became very interested in Chemistry and for much of College. I was going to go to graduate school in Chemistry. And luckily, when I was in college, I came under the influence of an infectious disease doc named Elliot Kieff. And he and I became very good friends. He was chief of infectious disease at the University of Chicago at that time. And over about two years, Elliott convinced me to drop the Chemistry thing and go to Medical school. And I applied to Medical school late, because I was so late in making that decision. I got into the University of Chicago and stayed there because my support system was there. And then in Medical school came across another gentleman. I've been very fortunate to have good mentorship and good people. They influenced me over the years. John Altman, who was one of the original medical oncologists back in the 1950s when there was arguments about how we should be staging people. Should there be four stages or three stages, and that sort of thing is when John really cut his teeth in Oncology. He became a great lymphoma doc. John took me under his wing while I was in Medical school, and pretty much open the world up to me, and explained to me how the world rotates in Medicine. And that heavily influenced me. Told me to go into Oncology because I still had an interest in Policy. And he said there's going to be a lot of policy in oncology in the future, and the best way to get involved with it is to get your credentials as a medical oncologist. And in many respects, I think in the early 1980s, John was thinking I was going to be chief medical officer of the American Cancer Society, which I obtained in 2007. PAT LOEHER: Wow. Yeah. We want to hear more about that. I just have to throw this in parenthetically that one of the things I did here is that I applied late to Medical school and got into the University of Chicago. I just wanted to know that I applied early, and there was a lesser known school in Chicago that sent me a rejection letter. And not only did they reject me, the last line of it says, good luck in whatever career you decide to go into, meaning that, if you can't get into our school, there's no way you'll be a physician. So I really admire you. DAVID JOHNSON: Yeah. I applied late too and-- PAT LOEHER: Got into Vanderbilt. DAVID JOHNSON: No. No. No, no. I didn't go to Vanderbilt. I only got into accepted to one medical school, and it was late. I was just like my career as a chief. And I was, like, the last person admitted to my class in med school. That's unbelievably interesting. Tell us, was John your influence to go to the NCI? Or what prompted you to choose the NCI for your medical oncology training? OTIS BRAWLEY: Actually, John was very influential in that decision. I told him I wanted to go into medical oncology when I was a resident in Cleveland. And he said, Otis, in his Austrian accent, I have been expecting this phone call. And he then told me where I was going to apply and gave me a list of nine places to apply. He told me I would get an interview at every one of those places. And as I was going place to place, I should rank them one, two, three, four. And so I called them with his ranking. And my first choice was not the National Cancer Institute. At which point he told me, if you go to that place, I will never speak to you again. PAT LOEHER: Oh wow. OTIS BRAWLEY: And I said, but you told me to go there to interview. He said, I wanted you to interview there, but I don't want you to train there. And I said, well, my first choice is the National Cancer Institute. And he said, fine. And a couple of days later, I got a phone call from the National Cancer Institute, and I got hired. And I will also tell you I called John up. And he says, Otis, I have been expecting this phone call. And then he said, now I want you to realize something. There is an old boys network, and your job is to get more Blacks and women into it. That's how you will thank me. PAT LOEHER: Wow. Wow. DAVID JOHNSON: So you were at the NCI at a period of time where many people would say it was the heyday of the NCI. I think it's still the heyday now, but tell us about your experiences there. What was it like? OTIS BRAWLEY: It was fascinating. It was when Vince DeVita was still the director. I was there for the transition. Eli Glatstein was the chair of Radiation Oncology. It was an amazing group of people. Dan Longo was there doing lymphoma. Marc Lippman was still there doing breast. It was just an amazing group of people when I applied, and interviewed, and when I first got there. And there was still a lot of excitement. We were still heavily involved in chemotherapy. Of course, I was up on the 12th and 13th floor building 10. Down on the second and third floor was Dr. Rosenberg doing his immunotherapy work, which of course, has now paid off dramatically. Some of the old monoclonal antibody work that led to a number of wonderful drugs was being started at that time in the mid to late 1980s. And so it was still a very, very exciting time at the National Cancer Institute. And in many respects, we were still on that burst of optimism that started with Nixon's war on cancer in 1971. It was still felt almost 20 years later at the National Cancer Institute. DAVID JOHNSON: And you linked up with an old friend of mine from the old Southeast Cancer City, a gentleman by the name of Barry Kramer? OTIS BRAWLEY: Yes. DAVID JOHNSON: What a wonderful relationship. So how influential was Barry in your involvement? OTIS BRAWLEY: Barry was incredibly influential. As I said, I have been very fortunate that along the way I have come under the influence of some amazing physicians, and I've had amazing mentorship. And that's actually, I think, important for all of us in oncology. Barry and I got to work together for quite a long while. Barry influenced me and literally taught me epidemiology. Got me some major opportunities at the National Cancer Institute and really was influential in promoting me and boosting my career. PAT LOEHER: I want to move you a little bit longer in your career and talk about the ACS and a little bit your experience there, Otis. And then with that, actually, maybe the secondary question is, a commentary on the leaders over the years that you have had-- the aspects of good things about leadership and the poor things. And obviously, you have certainly much to share on that. OTIS BRAWLEY: Yeah. Well, as I devote my career at the National Cancer Institute, I went to the Division of Cancer Prevention and Control. Under Barry, learned a lot of epidemiology, and learned a lot about screening, learned a lot about treatment outcomes, got very involved with some of the disparities or minority health issues. And then I was very fortunate to be detailed to work in the surgeon general's office and work with David Satcher when he was surgeon general. He's the one who started using the words, health disparities. Prior to that, we called it minority health or special populations. He used health disparities. And I was able to use some of my epidemiologic talents to develop some of those arguments using science to show. And actually some of the things that we had to show, believe it or not, was we had to show that equal treatment yields equal outcome amongst equal patients, because a lot of people, especially the politicians we need to deal with, were really hung up. And we still see this to this day that people are hung up that Black biology is different from white biology. Even in breast cancer today I hear that even though I like to point out there are now six states where the Black death rate for breast cancer is the same as the white death rate for breast cancer. And there are 12 states in the United States where white women have a higher risk of death from breast cancer than Black women in Massachusetts. But anyway, we got into this biology thing. And so I was very fortunate again to work for David Satcher and had some exposure to Tuskegee syphilis trial and the president's apology for that. So I was really involved with a number of things. And then the Jesuits still back there-- always think, always be contemplative, always reflect on what you're doing, always question what you're doing. Father Pawlikowski's maxims, which Dick Cheney sort of preferred is a few years later. And that is there are things you know, things you don't know, things you believe. Question what you know more so than anything else. And so that's really how I develop my concerns about orthodox use of Medicine. And using the science and applying it in a very Orthodox way, I started realizing that a lot of the disparities were due to wasted resources with people being non-scientific especially in the era of the 1990s, where everybody was doing prostate cancer screening, and there was not a single trial to show that prostate cancer screening saved lives. Yet all the resources were going into that, and people were literally-- I was able to go to various safety net hospitals and see all the resources being diverted away. People would shut down cervical cancer screening programs to do prostate cancer, which just didn't make sense. So I got very interested in how you practice medicine. Went to the Emory in 2001, because I wanted some practical experience outside of government. And had a wonderful opportunity to go there. Work at Emory. Work at one of the largest safety net hospitals in the country. Learn a little bit about the practical application of Medicine and some of the problems that people at safety net hospitals encounter. Worked with the School of Public Health and folks who did health education to learn how to convey messages. And then I was very fortunate. You know, the American Cancer Society is right down the street from Emory University. And I had met the chief medical officer of the American Cancer Society, Harmon Eyre, back in the 1990s when I was at the National Cancer Institute. And again this sort of mentoring thing comes up again. Harmon called me up one morning and said, why don't we go to lunch? And so we went to one of the student cafeterias at Emory and had lunch. And he essentially said, you know, I'm 67 years old. I've had this job for 20 years. I'm tired of it. Why don't you take it? PAT LOEHER: Wow. OTIS BRAWLEY: And so I applied to be chief medical officer of the American Cancer Society and got to know John Safran, who, at that time, was the CEO, who was a wonderful man with incredible vision. Again, this mentorship thing comes up again. PAT LOEHER: Well, Dave we had a lot of information here. We're going to carry this over. This concludes the first part of our two-part interview with Dr. Brawley. And our next episode will air on October 5. We'll talk a little bit more about Dr. Brawley's life experiences and particularly his work with the American Cancer Society NCI. He's been an incredible individual, and we look forward to finishing up this conversation. Thank you to all our listeners for tuning in to Oncology Et Cetera an ASCO Education Podcast, where we'll talk about anything and everything. If you happen to have an idea for a topic or guest you'd like to see on the show, please email us at education@ASCO.org. Thanks again. And remember Dave has a face for podcast. SPEAKER: Thank you for listening to this week's episode of the ASCO eLearning weekly podcast. To make us part of your weekly routine, click Subscribe. Let us know what you think by leaving a review. For more information, visit the comprehensive e-learning center at elearning.asco.org.

With the ubiquity of fanzines, blogs and podcasts in the 21st century, anyone can publish their critiques on any form of the arts (including your humble hosts of this very show). For better or worse, we don't have to limit ourselves to the opinions of those who claim to “know better”. There was a time, though, where we'd have to rely on information and analysis about music from the writers at publications like NME, RAM, Juke, Rolling Stone or any number of music magazines.Welcome to episode 87 of See Hear Podcast.In 1969 in that most rock and roll of cities Detroit, publisher Barry Kramer and founding editor Tony Reay created Creem magazine. Unlike, the recently founded Rolling Stone which portrayed rock music as a serious artform, Creem was taking the piss out of popular culture – very much in line with counter culture values. It featured writers who would be gain fame and infamy like Lester Bangs, Dave Marsh, Cameron Crowe, Robert Christgau and Greil Marcus among many others who obviously loved the music being created but without being held hostage to its creators. The writers showed no fear no favour in how they wrote about bands. MC5 and Rolling Stones, “Exile On Main Street” received less than favourable reviews to start with, something that seems unfathomable now.We're proud to welcome to the show, documentarian Scott Crawford to discuss his latest film, “Creem: America's Only Rock and Roll Magazine”. He had access to many of the surviving key players from the magazine's 20 year run and has come up with a fascinating look at how Creem was different from its competitors and why it was so beloved of many musicians. There's a gem of a story involving Lester Bangs, Dave Marsh, a typewriter and a dog. Wanna know more? Tune in.Our huge thanks to Scott for being such a great conversationalist and for allowing us to spend time with him to talk about a truly interesting part of rock history. We at See Hear highly recommend you watch this film....here's a number of ways you can stream it. (Depending on where you are, you may need a VPN). https://www.creemmovie.com/watch-at-home/Scott also has a great podcast called Spoke which you can check out here: https://www.listennotes.com/podcasts/spoke-scott-crawford-0zTir9pbt-A/If you've been enjoying the show, please consider giving us a favourable review on iTunes and let your friends know that our show exists. If you don't enjoy the show, please tell your friends to tune in anyway.See Hear is proudly part of the Pantheon Network of music podcasts. Check out all the other wonderful shows at http://pantheonpodcasts.com. The list of new shows is always increasing.Send us feedback via email at seehearpodcast@gmail.comJoin the Facebook group at http://facebook.com/groups/seehearpodcastCheck out the Instagram page at www.instagram.com/seehearpodcast/?hl=enYou can download the show by searching for See Hear on whatever podcast app you favour.

With the ubiquity of fanzines, blogs and podcasts in the 21st century, anyone can publish their critiques on any form of the arts (including your humble hosts of this very show). For better or worse, we don't have to limit ourselves to the opinions of those who claim to “know better”. There was a time, though, where we'd have to rely on information and analysis about music from the writers at publications like NME, RAM, Juke, Rolling Stone or any number of music magazines. Welcome to episode 87 of See Hear Podcast. In 1969 in that most rock and roll of cities Detroit, publisher Barry Kramer and founding editor Tony Reay created Creem magazine. Unlike, the recently founded Rolling Stone which portrayed rock music as a serious artform, Creem was taking the piss out of popular culture – very much in line with counter culture values. It featured writers who would be gain fame and infamy like Lester Bangs, Dave Marsh, Cameron Crowe, Robert Christgau and Greil Marcus among many others who obviously loved the music being created but without being held hostage to its creators. The writers showed no fear no favour in how they wrote about bands. MC5 and Rolling Stones, “Exile On Main Street” received less than favourable reviews to start with, something that seems unfathomable now. We're proud to welcome to the show, documentarian Scott Crawford to discuss his latest film, “Creem: America's Only Rock and Roll Magazine”. He had access to many of the surviving key players from the magazine's 20 year run and has come up with a fascinating look at how Creem was different from its competitors and why it was so beloved of many musicians. There's a gem of a story involving Lester Bangs, Dave Marsh, a typewriter and a dog. Wanna know more? Tune in. Our huge thanks to Scott for being such a great conversationalist and for allowing us to spend time with him to talk about a truly interesting part of rock history. We at See Hear highly recommend you watch this film....here's a number of ways you can stream it. (Depending on where you are, you may need a VPN). https://www.creemmovie.com/watch-at-home/ Scott also has a great podcast called Spoke which you can check out here: https://www.listennotes.com/podcasts/spoke-scott-crawford-0zTir9pbt-A/ If you've been enjoying the show, please consider giving us a favourable review on iTunes and let your friends know that our show exists. If you don't enjoy the show, please tell your friends to tune in anyway. See Hear is proudly part of the Pantheon Network of music podcasts. Check out all the other wonderful shows at http://pantheonpodcasts.com. The list of new shows is always increasing. Send us feedback via email at seehearpodcast@gmail.com Join the Facebook group at http://facebook.com/groups/seehearpodcast Check out the Instagram page at www.instagram.com/seehearpodcast/?hl=en You can download the show by searching for See Hear on whatever podcast app you favour. Learn more about your ad choices. Visit megaphone.fm/adchoices

With the ubiquity of fanzines, blogs and podcasts in the 21st century, anyone can publish their critiques on any form of the arts (including your humble hosts of this very show). For better or worse, we don't have to limit ourselves to the opinions of those who claim to “know better”. There was a time, though, where we'd have to rely on information and analysis about music from the writers at publications like NME, RAM, Juke, Rolling Stone or any number of music magazines.Welcome to episode 87 of See Hear Podcast.In 1969 in that most rock and roll of cities Detroit, publisher Barry Kramer and founding editor Tony Reay created Creem magazine. Unlike, the recently founded Rolling Stone which portrayed rock music as a serious artform, Creem was taking the piss out of popular culture – very much in line with counter culture values. It featured writers who would be gain fame and infamy like Lester Bangs, Dave Marsh, Cameron Crowe, Robert Christgau and Greil Marcus among many others who obviously loved the music being created but without being held hostage to its creators. The writers showed no fear no favour in how they wrote about bands. MC5 and Rolling Stones, “Exile On Main Street” received less than favourable reviews to start with, something that seems unfathomable now.We're proud to welcome to the show, documentarian Scott Crawford to discuss his latest film, “Creem: America's Only Rock and Roll Magazine”. He had access to many of the surviving key players from the magazine's 20 year run and has come up with a fascinating look at how Creem was different from its competitors and why it was so beloved of many musicians. There's a gem of a story involving Lester Bangs, Dave Marsh, a typewriter and a dog. Wanna know more? Tune in.Our huge thanks to Scott for being such a great conversationalist and for allowing us to spend time with him to talk about a truly interesting part of rock history. We at See Hear highly recommend you watch this film....here's a number of ways you can stream it. (Depending on where you are, you may need a VPN). https://www.creemmovie.com/watch-at-home/Scott also has a great podcast called Spoke which you can check out here: https://www.listennotes.com/podcasts/spoke-scott-crawford-0zTir9pbt-A/If you've been enjoying the show, please consider giving us a favourable review on iTunes and let your friends know that our show exists. If you don't enjoy the show, please tell your friends to tune in anyway.See Hear is proudly part of the Pantheon Network of music podcasts. Check out all the other wonderful shows at http://pantheonpodcasts.com. The list of new shows is always increasing.Send us feedback via email at seehearpodcast@gmail.comJoin the Facebook group at http://facebook.com/groups/seehearpodcastCheck out the Instagram page at www.instagram.com/seehearpodcast/?hl=enYou can download the show by searching for See Hear on whatever podcast app you favour.

With the ubiquity of fanzines, blogs and podcasts in the 21st century, anyone can publish their critiques on any form of the arts (including your humble hosts of this very show). For better or worse, we don't have to limit ourselves to the opinions of those who claim to “know better”. There was a time, though, where we'd have to rely on information and analysis about music from the writers at publications like NME, RAM, Juke, Rolling Stone or any number of music magazines. Welcome to episode 87 of See Hear Podcast. In 1969 in that most rock and roll of cities Detroit, publisher Barry Kramer and founding editor Tony Reay created Creem magazine. Unlike, the recently founded Rolling Stone which portrayed rock music as a serious artform, Creem was taking the piss out of popular culture – very much in line with counter culture values. It featured writers who would be gain fame and infamy like Lester Bangs, Dave Marsh, Cameron Crowe, Robert Christgau and Greil Marcus among many others who obviously loved the music being created but without being held hostage to its creators. The writers showed no fear no favour in how they wrote about bands. MC5 and Rolling Stones, “Exile On Main Street” received less than favourable reviews to start with, something that seems unfathomable now. We're proud to welcome to the show, documentarian Scott Crawford to discuss his latest film, “Creem: America's Only Rock and Roll Magazine”. He had access to many of the surviving key players from the magazine's 20 year run and has come up with a fascinating look at how Creem was different from its competitors and why it was so beloved of many musicians. There's a gem of a story involving Lester Bangs, Dave Marsh, a typewriter and a dog. Wanna know more? Tune in. Our huge thanks to Scott for being such a great conversationalist and for allowing us to spend time with him to talk about a truly interesting part of rock history. We at See Hear highly recommend you watch this film....here's a number of ways you can stream it. (Depending on where you are, you may need a VPN). https://www.creemmovie.com/watch-at-home/ Scott also has a great podcast called Spoke which you can check out here: https://www.listennotes.com/podcasts/spoke-scott-crawford-0zTir9pbt-A/ If you've been enjoying the show, please consider giving us a favourable review on iTunes and let your friends know that our show exists. If you don't enjoy the show, please tell your friends to tune in anyway. See Hear is proudly part of the Pantheon Network of music podcasts. Check out all the other wonderful shows at http://pantheonpodcasts.com. The list of new shows is always increasing. Send us feedback via email at seehearpodcast@gmail.com Join the Facebook group at http://facebook.com/groups/seehearpodcast Check out the Instagram page at www.instagram.com/seehearpodcast/?hl=en You can download the show by searching for See Hear on whatever podcast app you favour. Learn more about your ad choices. Visit megaphone.fm/adchoices

Join Barry Kramer and Lockstin (Gnoggin) as they help Arlo round out the first whole month of Arlocast by chatting about Skyward Sword HD's new features, lamenting some of the difficulties of content creation, and quizzing Lockstin on Pokemon Lore.   Be sure to follow @Arlocast on Twitter for updates and to get in on the fun!   For business inquiries, please contact arlocastofficial@gmail.com   Arlocast is edited and produced by Chris Jones.   Music by Northnann https://soundcloud.com/northnan   Logo art by Mario Castañeda https://wrackune.artstation.com   Many thanks to our guests!   Lockstin (Gnoggin) YouTube: https://www.youtube.com/user/Lockstin2 Twitter: @Lockstin   Barry Kramer YouTube: https://www.youtube.com/barrykramer Twitch: https://www.twitch.tv/barryisstreaming Twitter: @razzadoop

#barrykramer​ #howaboutthisgame​ #kingdomhearts ​If you wanna come hang out and talk like me and Barry did in this video, join the discord using this link https://discord.gg/Mqc5nGU You know Barry? He's a sweetie. Go watch his Death Stranding video. Follow him on twitter @razzadoop Check out his content at : https://www.youtube.com/channel/UC16f...​AND https://soundcloud.com/barryisstrumming​ ======================================== Subscribe for more ILLREVIEWANYTHING content Follow me on Twitter @ILLREVIEWANY

Dr Hayes interviews Dr Ganz on pioneering quality of life studies. PRESENTER 1: The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. PRESENTER 2: Welcome to JCO's Cancer Stories: The Art of Oncology, brought to you by the ASCO Podcast Network, a collection of nine programs covering a range of educational and scientific content and offering enriching insight into the role of cancer care. You can find all of the shows, including this one, at podcast.asco.org. DANIEL HAYES: Today, my guest on the podcast is Dr. Patricia A., Patti Ganz. Dr. Ganz has been a pioneer in establishing an entire field in our discipline, the discipline of survivorship. And really, this has been based on studies of quality of life and toxicities of therapy in patients with established active cancers that Dr. Ganz was involved with for really, the last four decades. Dr. Ganz was born and raised in Los Angeles. She received her undergraduate degree at Radcliffe, graduating in 1969. And correct if I'm wrong, Patti, I understand you were in the last class before the merger with Harvard. But I see you got your degree from Radcliffe and Harvard. So she received her medical degree and completed her residency and incidentally was chief resident and then medical oncology fellowship, all at UCLA. She then joined the faculty at UCLA and spent much of the early part of her career at the UCLA associated VA hospital. In 1992, she moved back to the mothership where she is now professor of medicine in the David Geffen School of Medicine, a professor of health policy and management in the Fielding School of Public Health, a distinguished professor of medicine and health policy and management, and the associate director for population science research in the Johnson Scott Comprehensive Cancer Center, again, all at UCLA. Dr. Ganz has authored over 400 peer reviewed papers, way too many chapters and reviews for me to recount here. And since 2017, she served as editor-in-chief of the Journal of the National Cancer Institute, one of the leading journals in oncology. She has an enormous list of honors that, again, is too long for me to go through today, except for a few I'd like to highlight. She's received two of ASCO's highest honors, the American Cancer Society award in 2008, and the Joseph B. Simone award for excellence in quality and safety in the care of patients with cancer in 2016. She was also the recipient of the Ellen L. Stovall award for the advancement of cancer survivorship care. She was a founding member of the National Coalition of Cancer Survivorship, and she was inducted into the Institute of Medicine, now designated the National Academy of Medicine, in 2007. And she's really played a major role in the efforts of the Academy to improve quality of care in medicine and particularly in oncology. Dr. Ganz, welcome to our program. PATRICIA GANZ: Thanks, Dan. It's great to be with you. DANIEL HAYES: So just to start out, there are so many things I'd like to talk to you about. One of those, in my opinion, you've been the epitome of role models for women in academics. And a lot of this series has mostly been men, because it was mostly men who started a lot of what we do way back 40, 50, 60 years ago. I know you grew up in LA. What shaped your decision to go into medicine in the first place, and then to stay in academics? PATRICIA GANZ: I went through college at Harvard and Radcliffe in a very turbulent time, in the late 1960s. Social issues were very important to us then, political issues just as they are now. And I was a biology major. And I was thinking about what I would be doing in the future. And for me, I really felt that I had to do something connected with people. And that was part of my decision. But of course, I had a major influence from my father, who was a physician. He actually went to the University of Michigan. And he always encouraged me to think about medicine, although he said ophthalmology, radiology, those are good careers for women. So you know, I had this lurking in the background. I didn't want to necessarily do exactly what my parents said to me. My mother was someone who also had been working in a family business for many years. So I had them behind me saying it was possible to have a career and to move forward in medicine. And of course, summers, doing various kinds of research that was involved with a potential career in medicine. So it wasn't a big surprise. Now why did I come back to LA? I guess that's a good question. Nowadays, when people actually are applying to medical school, I think they apply to 20, 30, 40. In those days, I think I only applied to six, if you can believe it. And three of them were UCs, and three or four of them I guess where on the east coast, or Northwestern with another one. It was a tough time. It was just on the feminist movement, also social change in terms of more African-Americans being admitted to medical school. And it was a tough time for those who were underrepresented, such as women. And in fact, at Harvard Medical School, I think family took 10 women. UCSF maybe took seven or eight women, where I'd gotten accepted there. And when I finally went back to school at UCLA, there were only three women in my class. So again, quite a striking difference than the way things are now. But I did come back to LA because UCLA was pass/fail. Having heard about the competition and medical school people being pretty cutthroat, I said, mm, probably good to go to a place where that wasn't the big issue. In addition, I actually met my future husband in a lab, working in a lab before my senior year in college. And I guess that might have been a motivation as well. DANIEL HAYES: And have you seen major change in attitudes regarding sex/gender in academics now? Do you feel that we've really made advances, or is it all just covering of a system that still exists? PATRICIA GANZ: I could speak for an hour on that, so I'm not going to do that. But I have to say that being a minority in the class was not unusual. Because at Harvard and Radcliffe, there were 300 women in my class at Radcliffe, and 1,200 men. And obviously, in the science classes I took, the women were in the minorities as well. But for women at that time, getting into medical school, they were actually a lot smarter and a lot better than the men because we were highly selected. However, my class, the three women-- one was me coming from an elite Ivy League school. One was a blonde valley girl who was coming from a California State University and another was a Korean immigrant. So we were all quite diverse-- yeah, even then. But by the time I graduated, we had a few women who transferred in. And actually, my husband who was a physicist at that time, went to medical school at UCLA five years later, and his class had about 25% women. So things were rapidly changing then. DANIEL HAYES: So I understand you really started doing hospice care when you were at the VA initially. And how has that colored what you ended up doing in terms of your career? I mean, in the 1980s, there wasn't a lot of hospice care. It must have made you think about and led to what you're doing now, what you've done. PATRICIA GANZ: That's an excellent question, Dan. And it was actually the late-- 1978, where I joined the faculty. And the chief of medicine said, you know, we have this kind of intermediate care unit. We'd like you to start a hospice for our oncology service, et cetera, et cetera. And there was actually a national hospice randomized trial that was going on at one of the other VAs here in Los Angeles. And having come out of my oncology training and thinking about it, I really thought well, you know, lot of those things that we're offering people at the end of life, like pain control and psychosocial support and things like that, we should really be doing that earlier for people. Because why should it just be reserved for those last few weeks? And so as I develop my unit at the VA, I actually called it a palliative care unit, a palliative care ward. Because at the VA I worked at, we had patients who actually often were in the hospital for five or six weeks getting their radiation, traveling by bus to the radiation facility. So they would be in for five days a week and then go home on the weekends. And these-- again, this was 1978, what were we seeing? We were seeing lung cancer. We had men with widespread prostate cancer who needed palliative radiation to the bones. We had a lot of colon cancers. So I was taking care of those patients. And while they weren't in imminent need of end-of-life care, they had trajectories which clearly were not good if they had advanced cancer. And it seemed reasonable-- I had a wonderful team, a physiatris, a psychologist, a social worker, even the pharmacist made rounds with us. It was just wonderful. And I essentially took all of the things that the palliative care end-of-life focus that hospice used and brought it up to the earlier part for some of these patients who, in fact, could be cured. I can think of someone who had localized small cell carcinoma who I took care of for many, many years. He was in getting chest radiation and whole brain. And you know, he lived a long time but he got all the tender, loving care that our nurses and our team were able to provide early in his course. DANIEL HAYES: You know, it segues really into my next question, which is in my own training, in the early 1980s at the Dana-Farber, especially led by Dr. Fry, Tom Fry, who's one of the fathers of medical oncology. We were really trained to learn how to treat and hopefully cure cancer. And there was very little regard to the toxicities. Dr. Fry used to tell us, cure the cancer first, we'll figure out the toxicities later. And at least the shackles begin to fall from my eyes as I began to see what you and others started to say. Well, you know, these people are going to survive. We need to worry about that. And personally, I think you almost-- not quite, but almost single-handedly taken our field beyond just treating the cancer, but worrying about the quality of life of survivorship. When you were starting that, either at the Bay area or when you went back to the main campus, what were the hurdles? Were there people who told you, you were wasting your time? Most have been told this is a fool's errand. You'll never get promoted by doing this kind of research. And you have done OK, I think. PATRICIA GANZ: Yeah. You know, I actually wanted to even go back to my training, you know? Because in the late '70s, there was actually-- in my heme/onc division, it was mostly liquid hematologists who were the leaders. And there were one or two solid tumor oncologists. And because I was interested in medical oncology primarily, I was the mentee of this person in his clinic. And essentially, what happened-- this was in the early days of adjuvant TMF chemotherapy. And you know, I was giving women chemotherapy for 12 months. And they didn't want to take it. They wanted to stop because of the toxicities of treatment. And he typically had me see those patients who needed that kind of support and symptom management and things like that, which were rather primitive, obviously, at that time. Because he was very technocrat in terms of knowing the literature and making those kind of decisions about therapy, but not managing all of this. So because of this collaborative relationship in his clinic for a couple of years, that's essentially where I began to see these issues because patients felt comfortable talking to me about it. Early on actually, at the VA, I was very fortunate, first of all, just to say I was a biology major in college. I never took a psychology class, ever. I took maybe a sociology class, which was on China at the time, but really wasn't trained in behavioral science. And I was very fortunate because there was a psychiatrist who was very interested in understanding the impact of cancer and its treatment on patients. And again, mind you, the five year survival was less than 50% at that time. And certainly, for the patients we saw with lung, colon, prostate that was metastatic, very much shorter. And he got a grant from the VA to do an intervention trial in the veterans and their spouses. But in order to be able to understand what patients were experiencing, Ian, the psychologist he hired as a project director, said, well, we've really got to interview patients and talk to them and find out what they're dealing with. And the psychological or psychosocial literature at that time was rife with issues related to coping. And coping is a concept that is not easy to explain to people. And certainly, it isn't necessarily universal in terms of many cultures. So it was difficult, then, to kind of operationalize this. And again, because I work with this great team, they began to interview our patients in clinic, and really, in detail, understood the day-to-day things that people were dealing with in terms of their cancer and the side effects from the treatment and their social relationships. And then we, all of a sudden, began to think of ourselves as a multidisciplinary team. And in fact, the person, Joe Collin, who was the associate director for population science at the Cancer Center at that time at UCLA, kind of said, gee, you make the ideal multidisciplinary team, you know-- a psychiatrist, a psychologist, and some medical oncologists. And it was from that time forward, that we began working together and I got my first grant. And really, they taught me so much about measurement, reliability, and validity. And in fact, we published our first paper together in JCO the second volume, which was on the Karnofsky performance status we visited, where they compared their ratings of the Karnofsky with my ratings of the Karnofsky for the clinic patients. And because they did a systematic interview about what patients were experiencing, noted that the function of patients was much worse than what I as even a sympathetic clinician would rate them. So that was really so important for me and working with them. And again, I think that's been the hallmark of my career to have had so many psychologists and psychiatrists, behavioral scientists, who embraced working with me, partly because I gave them access to patients if they wanted to study them, but I was also interested in really understanding, in a very rigorous way, how we could measure some of these things. DANIEL HAYES: Yeah, that raises another issue. In my career as a clinical investigator and translational investigator, pretty much inherited the tools to do what I want to do, how to do a clinical trial. It's always struck me that you, and I guess, Charles McKinsey and others had to make up your own tools, basically, to get it out of the realm of touchy-feely, if you will, and into the realm of true quantitative science so you could describe what you've done and how you've done it. How did you go about building those tools? PATRICIA GANZ: So again, a lot of these strategies or approaches to measurement were available in the social science literature. And they were just beginning to be translated into medicine. And again, this goes back to when I was training at UCLA. The Rand Health Insurance Experiment was going on in the '70s. My attendings in clinic were all involved in that. And John Ware, who was a great psychologist/methodologist, developed huge measures to look at patient outcomes in that big insurance experiment trial, which then got adapted into many other instruments that are widely used, such as the SF-36, and more recently, the Promise measures, which are publicly available. So I kind of was-- again, I had these kind of parallel streams of exposure. Health services research was very prominent at UCLA. These were my clinic attendings. And there was a very robust community of health services and health outcomes researchers. So I saw myself as kind of being an oncologist who could use those methods and apply them to the cancer problem. And there certainly weren't too many people out there. In addition, I had good fortune to begin to work in the cooperative groups, Ware and SWOG, with someone like Carol Moinpour, who led the efforts there in terms of patient-reported outcomes for many years, and then actually had a sabbatical in Switzerland, working with some of the IBCSG people and really having a time to just self-educate myself about this methodology. So I'm really self-educated, but have had wonderful collaborators who have kind of held my feet to the fire and said, you know, that's not rigorous enough, on occasion, certainly. DANIEL HAYES: So you were doing team science before the word came up, before the term. PATRICIA GANZ: Yeah, exactly. Certainly, when you have certain gaps in your knowledge, you need those collaborators. DANIEL HAYES: You know, this brings up-- I alluded to her just a moment ago. But when I think of cancer survivorship and quality of life, I think of you. But I think a lot of the late Jimmie Holland, who sadly passed away before I was able to interview her for this series. Can you just-- I think maybe some of our listeners don't know of her, haven't heard of her. We've got a lot of people young people listening to this. Can you just give a little background about Dr. Holland and the things she did? PATRICIA GANZ: Sure. Dr. Holland was a psychiatrist who really invented the field of psycho-oncology. And really, because she was working almost always in a cancer hospital, cancer setting-- I believe first at Roswell Park with her husband, James Holland-- she began to notice the neglect, if you will, of the impact of the cancer on the whole person and on the psychological aspects of cancer. And because of her being within a cancer hospital setting and then later moving to New York and obviously leading this effort at Memorial Sloan Kettering-- and really being very involved with CALGB and now the Alliance-- was able to introduce very early into the cooperative groups, the need for not just looking at the disease and its treatment, but to look at the after effects or show what were going on in the patient and how they were dealing with the illness. And she actually developed one of the first collaborative groups in psycho-oncology, which had people like Gary Morrow, who's at Rochester and who's had one of the big ENCORE research bases and has really continued to carry on a lot of psycho-oncology research across the country. Following what was really an early innovative approach, she developed a whole training program at Memorial. She trained many outstanding psychologists, psychiatrists working in this field and textbooks. I had the good fortune to work with Julia Rowland for a number of years. Julia was a direct descendant, if you will, Dr. Holland, having been at Memorial working with her and leading some of their early survivorship work. But she just trained probably more than a generation of people to take this seriously. As I kind of mentioned in an email to you, just as I would go to the ASCO meeting to listen to what Dr. Fisher or Dr. Bonadonna had to say, because I was interested in breast cancer and it was very exciting to hear the new reports of adjuvant therapy, I would also go to hear her and to Barry Castle, who was another leader in the field at the University of Pennsylvania, who basically were bringing rigor and clinical expertise to characterizing the patient experience, and publishing papers often in high profile journals like the New England Journal. So they were really role models for people who wanted to go into this field, although they weren't oncologists. And I think that's where I had kind of a double opportunity. Number one, I was perceived as a card-carrying oncologist. I was treating patients. I was in a cooperative groups. I was involved in trials, but I was also saying what about this secondary objective to our trial to look at the experience of the patients? So having entree to the patients, being perceived as one of the oncology community was, again, a really good thing to do. Although I must say that there were dozens and dozens of conferences where I was the last speaker on the program because quality of life was down there at the bottom-- not so much anymore. DANIEL HAYES: Your stories are great. I have one brief anecdote again, for the younger listeners. Jim and Jimmie Holland where as different as night and day. And Jim Holland, who was one of the three guys with Dr. Fry and Dr. Freireich-- who decided to put two drugs together and suddenly, we were able to cure some cancers-- was blustery. You might even call him a blowhard. I loved him, but I will never forget as a very junior person in CALGB, and I was appointed to be chair of a committee. And I was running my first committee meeting-- and needless to say, I was nervous anyway. And all of a sudden in the back of the room, Jim Holland, without a microphone, screams out something about, Hayes, if this is the way you think it's sounding, when I'm reading to you now, duh, duh-- so I went ahead and got through the reading. And later, Jimmie walked up to me and said, you know, he really loves you. His bark is much worse than his bite. PATRICIA GANZ: No, and you know, I think the early days of oncology were so much like that. Because again, we would have these wonderful people come to the microphone and ask a question. In the case of Dr. James Holland, he didn't need a microphone. But the point is, that we actually saw these people in real life, posing questions, challenging sometimes what was presented in a meeting, but also being very collaborative. And I think it was wonderful. And I think it's good that we have-- you know, our meetings today, obviously, are quite different because of the pandemic. But in our large meetings, we have scheduled discussions which is good, but it doesn't have the same spontaneity that we obviously were fortunate to experience in an earlier time. DANIEL HAYES: Yeah, I agree. You know, I think probably, of the many, many contributions and things you're known for, I believe your role in the Institute of Medicine then, now the National Academy of Medicine, regarding survivorship may be your greatest impact on what we do. How do you think that's translating now, to use the word translational science, which it really is? And when I was present, I was struck. There are probably 15 million cancer survivors in the United States right now. Have we really changed how they do based on your report, or is that falling on deaf ears? What do you think's going on with that? PATRICIA GANZ: Well, you know, there's several things that have happened. So the report that was in 2006 was led-- actually, Ellen Stovall was actually one of the co-leads of that committee. And you know, that was very seminal in that it was-- it's called the lost in transition report. And it really called out-- at that time, there were 10 million survivors, and that this whole large body of the population didn't really know, didn't have much direction about what to do after treatment and were kind of lost, because the oncology care system didn't really give them any guidance. And if somebody went to their primary care doctor, they would say, uh-oh. I don't know what that's about. You go talk to your oncologist. And then the oncologist would say, oh, that's a weird symptom, but it's not-- you know, you don't have any evidence of disease. That would be the typical thing. But it was usually an ongoing long-term effect of the treatment or possibly a late effect that was emerging, you know, such as a cardiac problem or a neurological problem that might be a secondary to previous treatment. And so the patients really weren't getting good care. And they kind of said we need there to be a group of people-- whether it's an oncologist or someone else-- who will take an interest and really tell us what do we need to be on the lookout for. And that was kind of a way to say, we need an end-of-treatment discharge summary. And it became actually very apparent. I was on the ASCO board actually during that time with the NICCQ report. I don't know if you remember that, but it was a report that ASCO did looking at the quality of care for breast and colorectal cancer patients. And what they found was you could find the op report from the surgeon. You could find the radiation therapist's summary note. But the chemotherapy flow sheets-- and this is, again, before electronic records-- were the only way you could even find out if somebody a series of treatments. And that went on, sometimes, over several years. So there was kind of no summary after the medical oncologists finished their treatment. So they try and figure out, even if you were the treating physician many years later and you needed to retreat someone, it was hard to know what was happening. So in some ways, the treatment summary and care plan had two roles. One was to say, well, what did they actually get? And the patient should know what they got in case many years later, you find out there's the late effects. But also, what do we need to look out for? And so really, again, building on what the childhood cancer survivor people had been doing for many, many years in terms of long term and late effects, this became an issue. Now Ellen Stovall, who was really focused on quality of care for cancer patients, and again, unfortunately, passed away a few years ago from complications of her Hodgkin's disease, really wanted there to be treatment planning and not just the treatment summary and care plan at the end of treatment. So I was actually fortunate in 2013 to lead another-- to lead, at this time, a report on quality of care and quality of care for cancer patients. Because Joe Simone had done one in the late '90s, and this was kind of a catch-up report. But it was also focused on the large and growing number of cancer patients, and many of them older. And with the baby boomers going into an age where cancer is very common, you know, how was our health care system going to approach this? And so we were, in that report, in many ways, echoing what had come about in the earlier survivor report, but saying you need to do this right from the very beginning. And it is very important for survivors. If we're going to be worried about fertility preservation, we need to do it right upfront. If we're going to be worried about potential complications in terms of cardiac toxicity occurring later, we need to be thinking about it in terms of planning the treatment for patients so that maybe they don't need to get chest radiation if they're a lymphoma patient. But chemotherapy and the very targeted therapies and the sensitive PET scans might help us avoid using unnecessary radiation to those individuals. So it has to be upfront thinking about what's going to have happen afterwards. And as part of the 2013 IOM report, we basically had many different recommendations which were kind of, I would say-- I kind of want to say pie in the sky, but futuristic. And one of them was that the insurers-- primarily Medicare, but other insurers-- should insist on patients having a treatment plan at the time of diagnosis, that their needs should be met, that they should have an understanding of the financial impact of the treatment decisions they're making, and that this should be part of a quality of care assessment strategy. And again, the thought was OK, maybe three, four, or five years from now, that will come about. But lo and behold, a year later, CMS picked this up and we had the development of the oncology care model, which in essence, took from our report the 10 or 13 point items that need to be part of initial coordinated care, which also included our survivorship care plan and treatment summary at the end of treatments. So I think to me, actually, that's one of the most significant accomplishments because now I see there's going to be a second version of the oncology care model, that many practices across the country have adopted these things. And as they've been part of the oncology care model, they're delivering this care to everyone, whether patients are insured by CMS or a private insurer. So I think this is an example of how long it takes to implement anything. Again, part of what I see our role, or my role as a health services researcher, is implementation science. If we know what works and what's important, it may take 15 years before it happens, but you need something like CMS to have a bundled payment plan. Or in the case of the treatment summaries and care plans, we have the American College of Surgeons who have championed that. And without these external regulatory policymaking organizations and payers, we don't get a lot of change. A long-winded answer, but to me, that's where the rubber hits the road. DANIEL HAYES: Well, I agree completely. I think that'll be your legacy, among many things. I mean, isn't it also part of the QOPI designation for QOPI accreditation in ASCO, isn't the survivorship plan? PATRICIA GANZ: Yes, the treatment summaries and care plans. I don't know-- I haven't seen any data. Recently, when I was more involved with the ASCO quality care committee, I saw some of those results. I don't know how compliant or adherent people are. But actually, part of the complaints that people have had has been, oh, it's hard to do this treatment summary. But if you actually start out with your initial treatment plan-- and we're actually doing this now on our Epic system at UCLA. There's something called the oncology history. And if you actually begin documenting from the beginning of treatment, you can actually move toward a treatment summary that's easily generated from the electronic record. But it's hard when you have to go back and do it retrospective. DANIEL HAYES: I was going to say, for all the young people who, at the end of a very long day, find themselves also having to do this long-term care plan for their patients, you could blame Patti Ganz for the work she started 30 years ago. PATRICIA GANZ: Yeah, OK. DANIEL HAYES: Actually, in the few remaining moments we've got, I want to bring up your new role as editor-in-chief of JNCI, the Journal of National Cancer Institute. I believe that you and Dr. Disis are the first women who have been editors-in-chief for major oncology journals. In fact, I don't believe it, I know it. You've been in the role now about three years. JNCI has always sort of had a niche that the other journals don't cover very well, in my opinion, and that they do. In taking it over, what are you keeping and what's your vision for the way you'll mold it in new ways and take it in new ways? PATRICIA GANZ: So I've been very fortunate, I was-- you know, I actually had a lot of experience at JCO as an associate editor for many years. And then I was also on the editorial board, and then deputy editor or associate editor and deputy editor of JNCI for quite a while as well. And Carmen Allegra took it over when Barry Kramer stepped down seven, eight years ago. And I knew Carmen from NSABP and RG. We had worked together closely. And I was kind of amazed when he took it over with all the obligations that he had as head of a heme/onc division and other roles, both leading gastrointestinal cancers at the NCI and NSABP Foundation. So he was doing a lot, and I thought, oh my gosh, you know? This is a difficult job to do as well. He basically moved the Journal a bit more towards a clinical perspective. And again, the history really is that JNCI was one of the first cancer journals. And maybe there was cancer research, but it was one of the first journals. And it essentially covered everything from soup to nuts, a lot of basic science. If you go back and see some of the highest cited papers, many different fundamental assays and so forth were published in JNCI. But if you look at the space in oncology, now there are 240-250 cancer journals so that we have many more outlets where some of the more basic science and translational science-- certainly, AACR has many wonderful journals-- so that we actually moved away, I think with Carmen's tenure, from the more basic work. And we really are taking almost no basic work. Things have to be clinical, in a sense that there has to be a translational component, cell line studies. And in vitro and animal models are not something that we're covering anymore. And again, that's a transition that I think occurred in prior years. I'm certainly continuing that. But I think because of my interest in breast cancer, obviously, and outcomes research in psychosocial work, we get more of those papers than perhaps when Carmen was the JNCI editor. But it's stiff competition, you know. We've had a strong epidemiological bent. We still get a lot of epidemiological and genetics papers. And I guess when I think about what I'm doing, it's really cancer prevention and control. That's what I've been doing for over 25 years, both in my academic research leadership position at UCLA, in my own research, and it's very broad. It's really applying all of the disciplines, if you will, of public health to the cancer problem, which means epidemiology, biostatistics, behavioral science, health outcomes research, you know, all of these things-- environmental science. All of these things are very important in both the etiology of cancer, the prevention of cancer, as well as the management of cancer. And so it's this cancer prevention and control swath that I think is our niche, if you will. So it's not as narrow as some journals. We're not just doing clinical trials, although we have them. But we're trying to have the broad scope of cancer prevention and control. That's pretty much how I see it. DANIEL HAYES: OK, thank you so much. Our time has come to an end. I can't tell you how much I appreciate your taking time to talk with us today. But more importantly, taking time to change the field of oncology in the way you have over the last 40 years. I think a lot of the things that our doctors are doing in clinic every day are a direct result of one person, and that's you. And there aren't many people who can say that. So thanks for all you do. Thanks for all your contributions, and I very much appreciate your sharing your history with us today. PATRICIA GANZ: Thanks so much, Dan. It was really a pleasure to speak with you and share what I've learned over time. Thanks so much. PRESENTER 2: Until next time, thank you for listening to this JCO's Cancer Stories: The Art of Oncology podcast. If you enjoyed what you heard today, don't forget to give us a rating or review on Apple Podcasts, or wherever you listen. While you're there, be sure to subscribe so you never miss an episode. JCO's Cancer Stories: The Art of Oncology podcast is just one of ASCO's many podcasts. You can find all the shows at podcast.asco.org.

Boy Howdy! “Creem: America’s Only Rock & Roll Magazine” is an amazing documentary that provides a magical look into the mythical world of the music rag that launched in 1969 in Detroit, Michigan (about a year after “Rolling Stone”), and inspired countless musicians (including Metallica’s Kirk Hammet and the Chili Peppers Chad Smith) to start bands. Creem epitomized the sex, drugs and rock & roll culture of the music industry in the 70s, helped propel KISS to rock star status, counted Alice Cooper, Iggy Pop and Lou Reed as fans, and unleashed a wild and disruptive newsroom into the homes of obsessed teens every month! Legendary journalist Jaan Uhelszki, director Scott Crawford, and JJ Kramer (son of Creem founder Barry Kramer) pull back the curtain and take us between the pages of “Creem!”

Boy Howdy! “Creem: America's Only Rock & Roll Magazine” is an amazing documentary that provides a magical look into the mythical world of the music rag that launched in 1969 in Detroit, Michigan (about a year after “Rolling Stone”), and inspired countless musicians (including Metallica's Kirk Hammet and the Chili Peppers Chad Smith) to start bands. Creem epitomized the sex, drugs and rock & roll culture of the music industry in the 70s, helped propel KISS to rock star status, counted Alice Cooper, Iggy Pop and Lou Reed as fans, and unleashed a wild and disruptive newsroom into the homes of obsessed teens every month! Legendary journalist Jaan Uhelszki, director Scott Crawford, and JJ Kramer (son of Creem founder Barry Kramer) pull back the curtain and take us between the pages of “Creem!”

”CREEM: America's Only Rock 'n' Roll Magazine" is a new documentary that tells the behind-the-scenes story of the legendary and controversial music publication, which turned 50 last year. Founding editor Jaan Uhelszki, documentary director Scott Crawford, and JJ Kramer, documentary producer and son of CREEM co-founder Barry Kramer, join us to talk about it.

Part 2 of 2 podcasts, devoted to the release of the new rock doc, Creem: America's Only Rock 'n' Roll Magazine. In this episode, we talk with Jaan Uhelszki, one of the founding editors at Creem and one of the first women to write nationally about rock n' roll. It's a fascinating road trip through the backyard of the Creem offices in the 70's. They were a group of outlaw writers, living in cramped quarters 24-7 and determined to reach rock readers with the unvarnished truth. Along the way, Jaan reveals rich stories on legendary misfits like Lester Bangs, Dave Marsh and Creem publisher, Barry Kramer. There probably isn't a rock icon that Jaan hasn't interviewed. In the 70 minute conversation (which does not drop in attention level), Jaan talks in great detail about Lou Reed, Neil Young, Ronnie Van Zant, Kiss, Ted Nugent, to name a few. Hear what it felt like, both intellectually and emotionally, to cover these seminal artists firsthand. Check show times and streaming info for the new Creem movie at www.creemmovie.com or their Facebook site.

 (0:00) Show Open:  More than 500 inmates at Arizona State Prison - of 48% of the unit's jail population - test positive for COVID-19 in a single day (7:55) Entertainment News   YouTube star Jake Paul's neighbors say they often hear 'mysterious explosions in the night' as it's revealed he has a $2M tax bill after FBI agents seized high powered weapons from his $6.9M LA mansion in connection to his mall riot arrest Twin YouTube stars Alan and Alex Stokes, 23, are charged with felonies after posing as bank robbers in prank video that resulted in Uber driver being held at gunpoint by police Dozens more women accuse Ron Jeremy of rape and sexual assault over 20 years, insisting the embattled porn star, 67, 'does things without asking' It's On!!! Brian Austin Green Expertly Trolls Megan Fox   (20:30) New Plastic Surgery Trend:  Couples Are Getting Their Genitalia Altered to Be More Compatible? The hot new trend in plastic surgery is . . . something called "genital matchmaking." That's where a couple both get plastic surgery to make their naughty regions more compatible. So a man might have his junk enlarged to better fit his wife or girlfriend's lady parts.  And she might have a rejuvenation or tightening down there to match up better with what he's packing. And the result is supposed to be more FRICTION during sex. We couldn't find any plastic surgeons listing prices for this procedure online, so you'll have to see what your favorite plastic surgeon quotes you. (Daily Mail) (27:15) Nils Lofgren Promoting: E-Street Band & Crazy Horse Guitarist Releases New Double Live Album In between E Street Band and Crazy Horse work, Nils Lofgren fit in his first tour with a full band in over 15 years.  The result is an earthy, rockin' double live album that breathes life into a world temporarily void of the excitement, energy, tenderness, and spontaneity of live music during COVID-19. The 16-track collection was recorded on the road during select intimate tour dates in the U.S. supporting his recent ‘Blue With Lou' studio album. The album contains live renditions of two of the Lou Reed/Nils Lofgren penned songs, “Don't Let Your Guard Down” and “Give,” along with Nils' rocking protest song “Rock or Not” and the tenderly wistful “Too Blue to Play”. Available August 21^st @ Amazon.com, itunes, & NilsLofgren.com  (38:00) Dumbass of the Day   Police Catch a "Tall Leprechaun" Breaking into Cars A Guy Lights 100 Candles to Propose to His Girlfriend . . . And Burns Their Apartment Down A Taxi Driver Stabs a Passenger Who Won't Stop Passing Gas in His Car   (47:05) Doctors Call For Arizona Department Of Health Services Director's Resignation Nearly 200 Arizona physicians are calling on the director of Arizona's Department of Health Services to resign. The doctors sent a petition to the department Wednesday. The letter says Dr. Cara Christ failed to take meaningful actions to slow the spread of COVID-19. The doctors say medical evidence for the effectiveness of masks and social distancing measures should have been communicated to Arizonans sooner in the pandemic. “These are things that should have been clearly and strongly conveyed to the public without any gray zone so that the public can know how to act," said Dr. Dionne Mills, who helped organize the petition. Mills said doctors involved have repeatedly asked Christ to address concerns. “Most of the people in our group are actually treating COVID patients, which she is not," Mills said.  The group, known as Physicians for Science, Equity and Advocacy, is also calling for enforcement of a statewide mask mandate, closure of dine-in restaurants, and expanded testing and contact tracing.  What Does The Blackstone Group Want w/ Your DNA? Genealogy database Ancestry.com is selling 75% of itself to Blackstone Group for $4.7billion in deal that will give the asset manager access to DNA data of up to 18 MILLION members (56:40) Herb Stratford Films opening August 7 I Used to Go Here Following the launch of her novel, a 35-year-old writer is invited to speak at her alma matter by her former professor. After accepting the invitation, Kate finds herself becoming  enmeshed in the lives of a group of college students and not sure if she wants to go back to her grown-up life. Gillian Jacobs and Jermaine Clement star in the drama/comedy I Used To Go Here. Trailer - https://www.youtube.com/watch?v=xEYSD4-8FPA CREEM: America's Only Rock ‘n' Roll Magazine  (Doc) CREEM: America's Only Rock ‘n' Roll Magazine tells the story of the iconic magazine from its beginnings in Detroit, to its rise from underground paper to national powerhouse. It then follows its imminent demise following the untimely deaths of its visionary publisher, Barry Kramer, and its most famous alum and genius clown prince, Lester Bangs, a year later. Trailer - https://www.youtube.com/watch?v=GUcCMNRTZpI The Fight (Doc) * The Fight is an inside look at how several important legal battles are fought by the ACLU and the lawyers on the front lines. The film captures the wild ride and the thrill and the defeat in several deeply human battles around immigration, abortion, voting rights, transgender rights and more. A compelling and moving documentary. Trailer - https://www.youtube.com/watch?v=eK8Pj4kN0YQ Red Penguins (doc) Shortly after the collapse of the Soviet Union, the Pittsburgh Penguins and the Red Army hockey team formed a joint-venture that showed anything was possible in the new Russia. Red Penguins tells a story of capitalism and opportunism run amok - complete with gangsters, strippers and live bears serving beer on a hockey rink in Moscow. Trailer - https://www.youtube.com/watch?v=4ygfmfd0Ij4 Support the show: https://podcave.app/subscribe/the-world-famous-frank-show-4eehjczc See omnystudio.com/listener for privacy information.

Well, here it is, folks. Part one of the Intervention Net retrospective. What was Intervention Net? Was it a band? Was it a web series? Was it both? At one point in time, the RSS-Feed-Owner was living in New York City, Brooklyn to be specific, Bed Stuy, to be exact. He'd formed Tra-La-Log & D.I.G.I.T.A.L., he'd formed China Street, he'd formed High Chief. He'd played in Barry Kramer, Cha-Cha Heels, and Gay Marriage. He'd graduated Audio school and he'd edited the news at  a Telemundo station. Now he lived in Brooklyn where he worked temp-jobs during the day and recorded music ideas in his bedroom at night for a small audience of mice. Every once in a while he'd make it out to the Shenedoah Valley or Atlantic City to visit the infamous Brothers Vacovsky and for a short time he worked on a video project called "Roomies" with his friend Brian Clark (mentioned previously in the song "Waves"). After about a year of this, the RSS-Feed-Owner's dear old friends, Nick and Mike, made it to the city and they three moved to Sunset Park, Brooklyn where they started a NEW band and a NEW web-series called INTERVENTION NET. Intervention lasted about 3 years and 21 episodes. They played numerous shows in New York during the 2008-2009 period and a few in Austin and Houston after moving back to Texas in 2009. Some would say the RSS-Feed-Owner's friends saved his life, but you can decide for yourself after watching said life chronicled in the 21-episode web-series INTERVENTION NET  https://www.youtube.com/playlist?list=PL52A6F43E4F9107B9 // The music contained in this podcast spans their short discography and also included is a live performance from Austin, TX. It isn't perfect,  some would say shaky, in fact, but it is one of the only existing recording of this trio attempting these complicated ditties live, so maybe some of you who have ever put the hard-work of your blood, sweat, and tears into something can appreciate that. If not, well take a number and get in line with the rest of the drones. https://intnet.bandcamp.com // https://interventionnet.bandcamp.com //  Mike - Bass, VOX / Nick - Drums, VOX / Kevin - Guitar/VOX // "Roomies" - https://www.youtube.com/user/RoomiesShow // ringoftyranny@gmail.com // http://patreon.com/ringoftyranny // www.loganpatrickhill.com //  This podcast is 100% INTERVENTIONED. STAY TUNED FOR PART TWO All episodes of Grass Growing can be found at: http://ringoftyranny.podbean.com //

Thanks to everyone for showing up and participating in our 100th episode livestream bonanza! Big special thanks to: Barry Kramer: https://www.youtube.com/channel/UC16fG7-summGsrcqkkYb6hg Nitro Rad: https://www.youtube.com/channel/UC-3J5xNrAbTLbU1gN8mMpOA Download or subscribe via RSS feed: feeds.soundcloud.com/users/soundcloud:users:365723144/sounds.rss YouTube versions: https://www.youtube.com/channel/UC58jKMTseTHniEJBQLPdTdg 00:07:08 Liam on Shovel Knight: King of Cards 00:12:37 Matt on Chrono Trigger 00:14:47 George on Bojack Horseman 00:18:59 Barry Kramer on Goose Game, Frog Detecitve, endless indies 01:09:27 https://www.youtube.com/watch?v=oP8C2nmv3Ag 01:14:20 https://www.gamesradar.com/new-bioshock-game-confirmed/ 01:16:44 https://kotaku.com/redbox-is-ending-its-video-game-rentals-and-ill-miss-t-1840343387 01:26:24 https://www.youtube.com/watch?v=xNjGFUaorYc&t=3s 01:40:10 Listener calls Don't forget to send questions to: dadandsonspodcast@gmail.com Art by Strekks: twitter.com/Strekks Music by Amie Waters: https://amiewaters.bandcamp.com/

The Freep Film Festival starts next week with a gala screening April 10 for “Boy Howdy! The Story of Creem Magazine” at the Fillmore Detroit. On today’s episode, we feature three great interviews to preview some of what’s on offer during the festivities, which run through April 14: JJ Kramer, co-producer of “Boy Howdy!” JJ is the son of Barry Kramer, the founder and publisher of Creem Magazine, which launched in Detroit’s Cass Corridor in 1969 and billed itself as “America’s Only Rock ‘n’ Roll Magazine.” Steve Byrne, the executive director of the Freep Film Festival and the arts and entertainment editor by day for the Detroit Free Press. And finally, Jennifer Washington, maker of the documentary “God Said Give ‘Em Drum Machines: The Story of Detroit Techno,” which explores that genre’s roots in the 1980s. You can read about all this year’s films and find all the showtimes at freepfilmfestival.com. Support Daily Detroit by telling your friends about us, subscribing and leaving us a review on Apple Podcasts, or supporting our work for as little as $1 a month by becoming a Patreon member. Thanks for listening!

Special thanks to Barry Kramer for showing up! https://twitter.com/razzadoop https://www.youtube.com/channel/UC16fG7-summGsrcqkkYb6hg Download or subscribe via RSS feed: http://feeds.soundcloud.com/users/soundcloud:users:365723144/sounds.rss YouTube versions: www.youtube.com/channel/UC58jKMTseTHniEJBQLPdTdg 00:09:54 Barry plays Metroid: Other M 00:20:10 Liam talking about how FIFA Has an RPG story mode nowadays 00:28:09 https://www.youtube.com/watch?v=stM5wqOlfFM 00:34:02 The Boku No Hero Acadamia Movie 00:40:35 Barry on The Messenger 00:44:28 Matt dips his toe into Maple Story 01:01:12 "What's your favorite cute anime girl game, Barry? 01:04:26 https://blog.us.playstation.com/2018/09/18/introducing-playstation-classic-with-20-pre-loaded-games/ 01:13:43 https://kotaku.com/google-announces-project-stream-which-lets-you-stream-1829441501 01:24:26 https://venturebeat.com/2018/09/27/john-carmack-oculus-quest-will-end-up-competing-with-nintendo-switch/ 01:35:41 Barry Questions Don't forget to send questions to: dadandsonspodcast@gmail.com Art by Strekks: twitter.com/Strekks Music by Ace Waters: @motive-makes-a-man

Joining Liam this week to kick-start a new series of Final Games episodes after a long summer break is former Grump, editor, animator, video producer, voice actor and all-round talent, Mr. Barry Kramer. The former Game Grumps editor joins Liam to talk about 8 new wonderful games that he would take with him to his deserted island. In this bumper episode Liam and Barry talk at great length about game design, making games and what Barry’s been up to since! Enjoy! Don't forget to follow on Soundcloud and leave a comment about what you thought of Barry's choices! We'd love to hear what you the listeners think of the guest's choices and let's have a lovely discussion :) If you want to support the show, you can do on Patreon! Please go to: www.patreon.com/liamedwards You can also download this show on iTunes as well, just search for "Final Games". Please rate and review the show! apple.co/1QP0ciS Yuri Lowenthal: @yurilowenthal Please go check out Craig's excellent music on Soundcloud! Thank you to him for his excellent intro! @windmills-at-dawn @craigedycraig If you'd like to contact the show or Liam, or if you have any feedback please check out: @LiamBME @FinalGamesShow finalgamespodcast@gmail.com Final Games is hosted on Soundcloud at: @finalgamespodcast But is also available on iTunes, aCast and Stitcher!

The concept of overdiagnosis is pretty hard to get - especially if you've been educated in a paradigm where medicine has the answers, and it's only every a positive intervention in someone's life - the journey to understanding the flip side - that sometimes medicine can harm often takes what Stacey Carter director of Research for Social Change at Wollongong university described in an preventing overdiagnosis podcast last year as a “moral shock” - https://soundcloud.com/bmjpodcasts/preventing-overdiagnosis-2017-stacy-carter-on-the-culture-of-overmedicalisation This year, we asked some of the leaders in the field to describe what it was that opened their eyes to overdiagnosis and overtreatment - and recorded the session for you. You'll hear from Fiona Godlee, editor in Chief of The BMJ, Steve Woloshin and Lisa Schwartz, directors of the Center for Medicine and Media at The Dartmouth Institute, John Brodersen - professor of general practice at the University of Copenhagen, and Barry Kramer - director of the Division of Cancer Prevention at the U.S. National cancer institute. The

Nick and Kevin get scared on Halloween. Nick leaves a note on someone's windshield, sparking a HELL DEATH IN A PARKING GARAGE match on Monday before work. Also, in a Gross Glowing EXCLUSIVE, it's a blast from the past with a scary song by Barry Kramer.

In the final episode of The G Club, some lads talk about Cuphead. Club members: Barry Kramer ► https://twitter.com/razzadoop Ryan Magee ► https://twitter.com/elirymagee Matt Watson ► https://twitter.com/matthwatson Jory Griffis ► https://twitter.com/JoryGriffis

Loud bwam noise! It's time for Barry and Ryan to discuss Blade Runner 2049. Club members: Barry Kramer ► twitter.com/razzadoop Ryan Magee ► twitter.com/elirymagee

Barry and Ryan discuss Mario + Rabbids Kingdom Battle! Cool. Club members: Barry Kramer ► twitter.com/razzadoop Ryan Magee ► twitter.com/elirymagee

Barry, Suzy, Ryan, and Jory get jumpscared and talk about horror movies. Club members: Barry Kramer ► https://twitter.com/razzadoop Suzy Berhow ► https://twitter.com/Mort3mer Ryan Magee ► https://twitter.com/elirymagee Jory Griffis ► https://twitter.com/JoryGriffis

Arin, Barry, and Jory have a seat around the table and talk hero shooters. Club members: Arin Hanson ► https://twitter.com/egoraptor Barry Kramer ► https://twitter.com/razzadoop Jory Griffis ► https://twitter.com/JoryGriffis

Arin and Barry are joined by Jirard The Completionist to talk about completing games. Club members: Jirard ► http://bit.ly/2xQuLg1 Arin Hanson ► https://twitter.com/egoraptor Barry Kramer ► https://twitter.com/razzadoop

Some people come together and discuss predictions, wants and thoughts on Game of Thrones Season 7 and more. Club members: Barry Kramer ► https://twitter.com/razzadoop Arin Hanson ► https://twitter.com/egoraptor Suzy Berhow ► https://twitter.com/Mort3mer Ryan Magee ► https://twitter.com/elirymagee

The gang sits down and discusses the ins and outs of the Metal Gear series. Club members: Suzy Berhow ► https://twitter.com/Mort3mer Jory Griffis ► https://twitter.com/JoryGriffis Arin Hanson ► https://twitter.com/egoraptor Barry Kramer ► https://twitter.com/razzadoop

The importance of the SAT has significantly grown and has become competitive than ever. Listen as Felicia Gopaul discuss with guest expert Barry Kramer about the SAT and other essential information on how to prepare for college admission testing. Barry Kramer graduated Magna Cum Laude from the University of Pennsylvania and went to New York University School of Law. He …

Scott Crouch has frank discussions with business leaders Barry Kramer various issues facing real estate agents in todays market. Sure to be fierce conversations and some fun mixed in with YOU getting some insights and action steps to better your LIFE!!